Leaching of diethylhexyl phthalate from multilayer tubing into etoposide infusion solutions

American Journal of Health-System Pharmacy

Volumn 62, Issue 2, 2005, Pages 182-188

  Bagel Boithias, Sandrine ^a   Sautou Miranda, Valérie ^b   Bourdeaux, Daniel ^c   Tramier, Violaine ^c   Boyer, Anne ^d   Chopineau, Jean ^d  

^a SERVICE DE RHUMATOLOGIE   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

^c GMH

^d UFR Pharmacy   (France)

Author keywords

Antineoplastic agents; Concentration; Contamination; Diethylhexyl phthalate; Drug administration rate; Ethyl vinylacetate; Etoposide; Flow; Injections; Leaching; Plasticizers; Polyethylene; Polymers; Polyvinyl chloride; Stability; Storage; Tubing

Indexed keywords

ETOPOSIDE; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; POLYETHYLENE; POLYVINYLCHLORIDE;

ARTICLE; COMPARATIVE STUDY; EQUIPMENT DESIGN; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFUSION; LEACHING; MATERIALS TESTING; PRIORITY JOURNAL; SAFETY; SIMULATION; SYRINGE; TUBE; VALIDATION PROCESS;

EID: 18744406045     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/62.2.182     Document Type: Article

References (19)

1. Environment Canada and Health Canada. Canadian Environmental Protection Act, priority substances list assessment report. Bis(2-ethylhexyl) phthalate. www.hc-sc.gc.ca/hecs-sesc/exsd/pdf/bis_2_ethylhexyl_phthalate.pdf (accessed 2004 Oct 5).
2. Demoré B, Vigneron J, Perrin A et al. Leaching of diethylhexyl phthalate from polyvinyl chloride bags into intravenous etoposide solution. J Clin Pharm Ther. 2002; 27:139-42.
3. Gras C, Sautou-Miranda V, Bagel-Boithias S et al. Compatibility of etoposide solution with polyvinyl chloride and low density polyethylene containers and its stability in different storage conditions. Eur J Hosp Pharm. 2002; 8:33-40.
4. Pearson SD, Trissel LA. Leaching of diethylhexyl phthalate from polyvinyl chloride containers by selected drugs and formulation components. Am J Hosp Pharm. 1993; 50:1405-9.
5. Loff S, Kabs F, Witt K et al. Polyvinylchloride infusion lines expose infants to large amounts of toxic plasticizers. J Pediatr Surg. 2000; 35:1775-81.
6. Jobet-Hermelin I, Mallevais ML, Jacquot C et al. Proposition d'une concentration limite acceptable du plastifiant libéré par le poly(chlorure de vinyle) dans les solutions injectables aqueuses. J Pharm Clin. 1996; 15:132-6.
7. Hanawa T, Muramatsu E, Asakawa K et al. Investigation of the release behavior of diethylhexyl phthalate from polyvinylchloride tubing for intravenous administration. Int J Pharm. 2000; 210:109-15.
8. Loff S, Kabs F, Subotic U et al. Kinetics of diethylhexyl-phthalate extraction from polyvinylchloride-infusion lines. JPEN J Parenter Enteral Nutr. 2002; 26:305-9.
9. Kambia K, Dine T, Gressier B et al. High-performance liquid chromatographic method for the determination of di(2-ethylhexyl) phthalate in total parenteral nutrition and in plasma. J Chromatogr B Biomed Sci Appl 2001; 755:297-303.
10. Tickner JA, Schettler T, Guidotti T et al. Health risks posed by use of di-2-ethylhexyl phthalate (DEHP) in PVC medical devices: a critical review. Am J Ind Med. 2001; 39:100-11.
11. Rossi M. Neonatal exposure to DEHP (di-2-ethylhexyl phthalate) and opportunities for prevention. www.noharm.org/library/docs/ Neonatal_exposure _to_DEHP_and_opportunities_for.pdf (accessed 2004 Oct 5).
12. Health Canada. DEHP in medical devices: an exposure and toxicity assessment. www.hc-sc.gc.ca/hpfb-dgpsa/tpd-dpt/dehp_revised_risk_assessment_e. pdf (accessed 2004 Nov 29).
13. Center for Devices on Radiological Health. Safety assessment of di(2-ethylhexyl)phthalate (DEHP) released from PVC medical devices. Rockville, MD; 2001:1-58.
14. Shea KM; American Academy of Pediatrics Committee on Environmental Health. Pediatric exposure and potential toxicity of phthalate plasticizers. Pediatrics. 2003; 111:1467-74.
15. Center for Evaluation of Risks to Human Reproduction, National Toxicology Program. NTP-CERHR Expert Panel report on di(2-ethylhexyl)phthalate. Washington, DC: U.S. Department of Health and Human Services, 2000; report NTP-CERHR-DEHP-00.
16. Sjoberg P, Bondesson U, Kjellen L et al. Kinetics of di-(2-ethylhexyl) phthalate in immature and mature rats and effect on testis. Acta Pharmacol Toxicol. 1985; 56:30-7.
17. Akingbemi BT, Youker RT, Sottas CM et al. Modulation of rat Leydig cell steroidogenic function by di(2-ethylhexyl)phthalate. Biol Reprod. 2001; 65:1252-9.
18. Park JD, Habeebu SS, Klaassen CD. Testicular toxicity of di-(2-ethylhexyl) phthalate in young Sprague-Dawley rats. Toxicology. 2002; 171:105-15.
19. Kambia K, Dine T, Gressier B et al. Evaluation of childhood exposure to di(2-ethylhexyl) phthalate from perfusion kits during long-term parenteral nutrition. Int J Pharm. 2003; 262:83-91.